Cytotheryx, a growing Rochester biotech firm working on treatments for liver disease, recently received $60 million in financing to advance its research and development. CEO Dr. John Swart announced ...

A study reveals advances in the understanding and treatment of liver fibrosis, a serious complication in the context of metabolic fatty liver disease, also known as MASLD (metabolic ...

Scientists have discovered that blocking a key cellular enzyme thought to protect against fatty liver disease may instead ...

Children born to mothers who consume a high-fat, high-sugar diet during pregnancy and breastfeeding face a higher risk of ...

GENFIT highlighted new focus and development strategy in Acute On-Chronic Liver Failure (ACLF) ACLF is a very serious condition affecting ~294,000 1 2 patients with chronic liver diseases in the USA ...

In a breakthrough that brings bioengineered organs one step closer to reality, scientists have created lab-grown liver tissue capable of forming its own blood vessels. A team from Cincinnati ...

Your liver works tirelessly as your body’s natural filtration system, processing everything you consume and protecting you from harmful substances. When it comes to alcohol, however, this remarkable ...

Pedestrians walk by the Pfizer corporate headquarters in New York City (2020). On Monday the company said it was discontinuing development of a weight-loss drug in pill form. File Photo by John ...

Pfizer announced on Monday that it is halting development of its oral weight-loss pill after one patient experienced liver issues. The company said it halted development of danuglipron, an oral drug ...